NasdaqGM - Nasdaq Real Time Price USD

Apogee Therapeutics, Inc. (APGE)

40.62
-0.02
(-0.05%)
At close: May 16 at 4:00:01 PM EDT
40.62
0.00
(0.00%)
After hours: May 16 at 5:06:22 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
241,785
216,870
93,003
30,727
Operating Income
-241,785
-216,870
-93,003
-30,727
Net Non Operating Interest Income Expense
36,495
34,742
9,018
-9,058
Pretax Income
-205,290
-182,128
-83,985
-39,785
Tax Provision
101
18
0
--
Net Income Common Stockholders
-205,391
-182,146
-83,985
-39,785
Diluted NI Available to Com Stockholders
-205,391
-182,146
-83,985
-39,785
Basic EPS
-3.61
--
-3.36
-1.46
Diluted EPS
-3.61
--
-3.36
-1.46
Basic Average Shares
57,195.34
--
25,005.77
27,246.82
Diluted Average Shares
57,195.34
--
25,005.77
27,246.82
Total Operating Income as Reported
-241,785
-216,870
-93,003
-30,727
Total Expenses
241,785
216,870
93,003
30,727
Net Income from Continuing & Discontinued Operation
-205,391
-182,146
-83,985
-39,785
Normalized Income
-205,391
-182,146
-83,985
-39,785
Interest Income
36,495
34,742
9,018
92
Interest Expense
--
--
0
9,150
Net Interest Income
36,495
34,742
9,018
-9,058
EBIT
-241,785
-216,870
-93,003
-30,635
EBITDA
-241,418
-216,681
-93,003
-30,635
Reconciled Depreciation
367
189
0
--
Net Income from Continuing Operation Net Minority Interest
-205,391
-182,146
-83,985
-39,785
Normalized EBITDA
-241,418
-216,681
-93,003
-30,635
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 7/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
15.18
+4.40%
 
VRDN Viridian Therapeutics, Inc.
12.94
+2.54%
 
ORKA Oruka Therapeutics, Inc.
10.06
+6.34%
 
NUVL Nuvalent, Inc.
73.32
+3.27%
 
ELVN Enliven Therapeutics, Inc.
16.86
-5.39%
 
MLTX MoonLake Immunotherapeutics
37.62
-0.11%
 
EWTX Edgewise Therapeutics, Inc.
14.78
+2.28%
 
ACLX Arcellx, Inc.
58.78
+0.56%
 
KYMR Kymera Therapeutics, Inc.
30.25
+0.77%
 
DNTH Dianthus Therapeutics, Inc.
19.69
+5.01%